Reaction Details Report a problem with these data
Target
Malignant T-cell-amplified sequence 1
Ligand
BDBM403040
Substrate
n/a
Meas. Tech.
MTT assay
EC50
<20.0±n/a nM
Citation
 Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL Heterocyclic inhibitors of monocarboxylate transporter US Patent  US10329303 Publication Date 6/25/2019 
Target
Name:
Malignant T-cell-amplified sequence 1
Synonyms:
MCT-1 | MCT1 | MCTS1 | MCTS1_HUMAN | Multiple copies T-cell malignancies
Type:
Enzyme Catalytic Domain
Mol. Mass.:
20563.62
Organism:
Homo sapiens (human)
Description:
n/a
Residue:
181
Sequence:
MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK
  
Inhibitor
Name:
BDBM403040
Synonyms:
US10329303, Example 6
Type:
Small organic molecule
Emp. Form.:
C24H26F2N4O3S
Mol. Mass.:
488.55
SMILES:
CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(CO)c(F)cc3F)c2c(=O)n(C)c1=O |(-4.16,-6.29,;-4.16,-4.75,;-5.5,-3.98,;-2.83,-3.98,;-2.83,-2.44,;-1.49,-1.67,;-.03,-2.15,;.88,-.9,;2.42,-.9,;3.19,-2.24,;2.71,-3.7,;1.38,-4.47,;3.96,-4.61,;5.2,-3.7,;4.73,-2.24,;5.5,-.9,;-.03,.34,;.37,1.83,;1.86,2.23,;2.25,3.72,;3.74,4.12,;4.83,3.03,;1.17,4.81,;1.56,6.29,;-.32,4.41,;-.72,2.92,;-2.21,3.32,;-1.49,-.13,;-2.83,.64,;-2.83,2.18,;-4.16,-.13,;-5.5,.64,;-4.16,-1.67,;-5.5,-2.44,)|
Structure:
Search PDB for entries with ligand similarity: